Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 5/11/26 → 5/11/28 |
Funding
- Maze Therapeutics: $15,861.00
MZE782 - A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability and Efficacy of MZE782 in Adults with Phenylketonuria (PKU)
- Zarate, Yuri (PI)